Published in Chest on February 01, 2005
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44
Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol (2008) 1.42
Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis (2008) 1.20
Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.11
The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data. Int J Chron Obstruct Pulmon Dis (2013) 1.07
Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res (2007) 1.03
Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol (2008) 0.99
Gender differences in the association between C-reactive protein, lung function impairment, and COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.98
C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations. Inflammation (2013) 0.88
Not all smokers die young: a model for hidden heterogeneity within the human population. PLoS One (2014) 0.85
The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care. BMC Fam Pract (2006) 0.82
The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.80
C-reactive protein levels in stable COPD patients: a case-control study. Int J Chron Obstruct Pulmon Dis (2015) 0.77
17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome. Sci Rep (2016) 0.75
The Relationship between Cerebral Small Vessel Disease, Hippocampal Volume and Cognitive Functioning in Patients with COPD: An MRI Study. Front Aging Neurosci (2017) 0.75
Systemic inflammation in 222.841 healthy employed smokers and nonsmokers: white blood cell count and relationship to spirometry. Tob Induc Dis (2012) 0.75
Adiposity markers and lung function in smokers: a cross-sectional study in a Mediterranean population. BMC Pulm Med (2016) 0.75
Smoking exposure, loss of forced expiratory volume in one second and the risk of lung cancer among patients with malignant disease who present with cardiac or pulmonary symptoms: a cross-sectional study. Tob Induc Dis (2017) 0.75
Association of High Sensitive CRP Level and COPD Assessment Test Scores with Clinically Important Predictive Outcomes in Stable COPD Patients. Tanaffos (2015) 0.75
Forced Expiratory Volume in the First Second and Aldosterone as Mediators of Smoking Effect on Stroke in African Americans: The Jackson Heart Study. J Am Heart Assoc (2016) 0.75
The puzzling relationship between cigarette smoking, reduced respiratory function, and systemic inflammation. Chest (2005) 0.75
Association of bone mineral density with airway obstruction and emphysema. Tuberc Respir Dis (Seoul) (2012) 0.75
Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification. Pak J Med Sci (2017) 0.75
Proinflammatory cytokines in Egyptian elderly with chronic obstructive pulmonary disease. Lung India (2010) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA (2003) 4.88
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation (2003) 4.63
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest (2005) 4.41
Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16
Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 3.88
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.85
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 3.36
Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.93
Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82
COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J (2013) 2.81
The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med (2012) 2.54
Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.41
Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med (2002) 2.36
Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked general medical journals. Eur J Epidemiol (2004) 2.34
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med (2002) 2.26
Vascular risk in chronic obstructive pulmonary disease: role of inflammation and other mediators. Can J Cardiol (2012) 2.22
Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc (2005) 2.17
Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet (2012) 2.09
The obesity paradox in patients with peripheral arterial disease. Chest (2008) 2.09
Inhaled corticosteroids for chronic obstructive pulmonary disease. BMJ (2012) 2.04
The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med (2007) 2.04
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study. Am J Med (2002) 1.90
Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration (2007) 1.88
Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med (2005) 1.88
Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA (2004) 1.84
Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.80
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest (2007) 1.79
Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol (2009) 1.68
Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med (2002) 1.67
Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use? Am J Respir Cell Mol Biol (2011) 1.67
Airway wall thickness assessed using computed tomography and optical coherence tomography. Am J Respir Crit Care Med (2008) 1.64
Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia. Am J Med (2005) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Molecular signature of smoking in human lung tissues. Cancer Res (2012) 1.50
The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest (2012) 1.50
Statins reduce ambient particulate matter-induced lung inflammation by promoting the clearance of particulate matter, < 10 μm from lung tissues. Chest (2013) 1.46
Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses. Am J Respir Crit Care Med (2015) 1.44
Novel properties of statins: suppression of the systemic and bone marrow responses induced by exposure to ambient particulate matter (PM(10)) air pollution. Am J Physiol Lung Cell Mol Physiol (2012) 1.44
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44
Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients? Curr Opin Pulm Med (2007) 1.41
Integrative approach to quality assessment of medical journals using impact factor, eigenfactor, and article influence scores. PLoS One (2010) 1.39
Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol (2008) 1.38
The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med (2003) 1.36
The airway epithelium: more than just a structural barrier. Ther Adv Respir Dis (2011) 1.30
Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J (2008) 1.28
Can universal access to health care eliminate health inequities between children of poor and nonpoor families?: A case study of childhood asthma in Alberta. Chest (2003) 1.23
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.23
New and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.23
Marijuana and chronic obstructive lung disease: a population-based study. CMAJ (2009) 1.19
Asthma and COPD among aboriginals in Alberta, Canada. Chest (2002) 1.17
The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. J Allergy Clin Immunol (2012) 1.17
Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med (2008) 1.16
The role of female hormones on lung function in chronic lung diseases. BMC Womens Health (2011) 1.16
Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. Am J Respir Crit Care Med (2010) 1.16
Steroids for treatment of COPD exacerbations: less is clearly more. JAMA (2013) 1.12
The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One (2012) 1.12
Management of asthma among community-based primary care physicians. J Asthma (2005) 1.12
Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res (Phila) (2011) 1.10
Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol Biol (2010) 1.10
Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer. Am J Respir Crit Care Med (2005) 1.09
Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol (2005) 1.08
Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol (2007) 1.05
Divergence of mechanisms regulating respiratory burst in blood and sputum eosinophils and neutrophils from atopic subjects. J Immunol (2003) 1.05
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2012) 1.03
Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls. PLoS One (2013) 1.02
Effects of increased primary care access on process of care and health outcomes among patients with asthma who frequent emergency departments. Am J Med (2004) 1.01
The relationship between birth weight and childhood asthma: a population-based cohort study. Arch Pediatr Adolesc Med (2004) 1.01
Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med (2005) 1.01
Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. Am J Respir Cell Mol Biol (2010) 1.01
Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations. Chest (2013) 1.01
Interleukin-6: a red herring or a real catch in COPD? Chest (2008) 1.00
Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. Dis Markers (2009) 0.97
Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Intern Med (2008) 0.97
Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis. Respir Res (2010) 0.97
Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung (2004) 0.96
Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging. J Am Geriatr Soc (2009) 0.95
Is the aging process accelerated in chronic obstructive pulmonary disease? Curr Opin Pulm Med (2011) 0.94
Surfactant protein D: a lung specific biomarker in COPD? Ther Adv Respir Dis (2008) 0.93
Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res (2008) 0.93
Epidemic of lung cancer in patients with HIV infection. Chest (2013) 0.92